Landmark deal will see NHS patients gain access to personalised therapy, reveals NHS England

NHS England has announced a landmark deal, giving children and young people access to Novartis’ Kymriah (a chimeric antigen receptor T-cell, CAR-T, therapy) — a personalised therapy for the treatment of cancer.

More From BioPortfolio on "Landmark deal will see NHS patients gain access to personalised therapy, reveals NHS England"